A Study to Evaluate the 24 Hour Spirometric Effect (FEV1) of Fluticasone Furoate/Vilanterol Inhalation Powder (100mcg Fluticasone Furoate (FF)/25mcg Vilanterol (VI)) Compared With Salmeterol/Fluticasone Propionate Inhalation Powder (50mcg Salmeterol/500mcg Fluticasone Propionate (FP))

NCT01342913 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

528

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Fluticasone Furoate 100mcg/Vilanterol 25mcg
DRUG: Fluticaosne Propionate 500mcg/Salmeterol 50mcg

Sponsor

GlaxoSmithKline